POLE and acute myeloid leukemia: Here, we reveal that Ara-C, the first line chemotherapy agent for acute myeloid leukemia for the past 40 years is highly cytotoxic when incorporated by the replicative DNA polymerases, even in the presence of Polε exonuclease activity.